The Federal Trade Commission has given Lockheed Martin the go-aheadto buy Loral on the condition that it take measures to limit thepossibility of antitrust conflicts in the defense industry. TheFTC's concerns had delayed the consummation of the merger,
The Federal Trade Commission has given Lockheed Martin the go-ahead
to buy Loral on the condition that it take measures to limit the
possibility of antitrust conflicts in the defense industry. The
FTC's concerns had delayed the consummation of the merger, which
was announced earlier this year (SCAN 1/17/96).
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.